ReCode Therapeutics
Priyanka Sahni currently serves as a Research Associate II in Preclinical Translational Biology and Assay Development at ReCode Therapeutics, focusing on in vitro cytotoxicity assays, drug substance testing, and assay development for pre-IND and IND-enabling studies. Prior experience includes a Bioanalytics Co-op at Moderna, a Graduate Research Assistant role at Northeastern University's Bouvé College of Health Sciences, and a Cell Line Development position at Takeda, where cellular assays and mammalian cell culture were key responsibilities. Earlier roles involved quality control in clinical settings with Valuepoint Knowledgeworks and a position as a Clinical Data Analyst at Massachusetts General Hospital. Priyanka holds a Master of Science in Biotechnology from Northeastern University and a Bachelor of Science in Biotechnology from The University of Manchester, complemented by summer programs in Neuroscience and Psychology at Harvard University.
This person is not in any teams
This person is not in any offices
ReCode Therapeutics
1 followers
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.